Low-dose aspirin in polycythaemia vera: A pilot study

British Journal of Haematology

Volumn 97, Issue 2, 1997, Pages 453-456

  Barbui, T ^a   de Gaetano, G ^a   Finazzi, G ^a,a   Landolfi, Raffaele ^a,d   Marchioli, R ^a   Patrono, C ^a   Tognoni, G ^a   Capani, F ^a   De Carli, A ^a   Gambi, D ^a   Nenci, G G ^a   Tura, S ^a,b   Mandelli, F ^a,f   Rossi Ferrini, P ^a   Cortelazzo, S ^a   Vestri, O ^a   Finelli, C ^b   Nocentini, F ^b   Pogliani, E M ^c   Miccolis, I R ^c   Bizzi, B ^d   Rocca, B ^d   Tartagilione, R ^d   Angeli, G ^e   Di Blasio, A ^e   Di Pasquale, A ^e   Kramer, V ^e   Marfisi, R M ^e   Olivieri, M ^e   Sciulli, L ^e   Spoltore, R ^e   Montefusco, E ^f   Spadea, A ^f   Carotenuto, M ^g   Nobile, M ^g   Morelli, A ^g   Resegotti, L ^h   Ciocca Vasino, M A ^h   Rodeghiero, F ⁱ   Ruggeri, M ⁱ   more..

^a Ospedali Riuniti Bergamo   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^h MOLINETTE HOSPITAL   (Italy)

ⁱ Ospedale S Bartolo   (Italy)

Author keywords

Antiplatelet treatment; Aspirin; Polycythaemia vera; Randomized clinical trial; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME INHIBITION; EVENING DOSAGE; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; LIPID BLOOD LEVEL; LIPOGENESIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH DISEASE; THROMBOCYTE COUNT; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION;

EID: 84983134916     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.362682.x     Document Type: Article

References (9)

1. 2 production in human whole blood. Thrombosis Research, 37, 1-8.
2. Gruppo Italiano Studio Policitemia (1995) Polycythemia vera: the natural history of 1213 patients followed for 20 years. Annals of Internal Medicine, 123, 656-664.
3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet, ii, 349-360.
4. Landolfi, R., Ciabattoni, G., Patrignani, P., Castellana, M.A.L., Pogliani, E., Bizzi, B. & Patrono, C. (1992) Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood, 80, 1965-1971.
5. Landolfi, R., Rocca, B. & Patrono, C. (1995) Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment. Critical Reviews in Oncology and Haematology, 20, 203-222.
6. Patrono, C. (1994) Aspirin as an antiplatelet drug. New England Journal of Medicine, 330, 1287-1294.
7. Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M.A. & Peskar, B.A. (1980) Low-dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thrombosis Research, 17, 317-327.
8. Roderick, P.J., Wilkes, H.C. & Meade, T.W. (1993) The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. British Journal of Clinical Pharmacology, 35, 219-226.
9. Tartaglia, A.P., Goldberg, J.D., Berk, P.D. & Wasserman, L.R. (1986) Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Seminars in Hematology, 23, 172-176.